Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07200817

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

Comparison Between Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

Status
Recruiting
Phase
Study type
Observational
Enrollment
290 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.

Detailed description

Sepsis affects more than 30 million people annually worldwide and is one of the significant causes of death in critical patients worldwide. Any infected person can potentially develop sepsis, and the incidence of sepsis is as high as 1-2% of all hospitalized patients. Many potential sepsis biomarkers have been proposed, procalcitonin (PCT) and C-reactive protein (CRP) being the most frequently studied. The ratio of neutrophils to lymphocytes and platelets (N/LP) is a low-cost measure that can be obtained through routine blood tests and is often used to reflect the body's inflammatory state.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNeutrophils to Lymphocytes and Platelets ratio (N/LP)The Neutrophils to Lymphocytes and Platelets ratio (N/LP) will be measured

Timeline

Start date
2024-09-20
Primary completion
2026-03-19
Completion
2026-03-19
First posted
2025-10-01
Last updated
2025-10-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07200817. Inclusion in this directory is not an endorsement.

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Ou (NCT07200817) · Clinical Trials Directory